The acquisition of the home health and hospice provider Amedisys by the insurance mammoth UnitedHealth Group (NYSE: UNH) has far-reaching implications for the hospice community. The UnitedHealth Group subsidiary Optum, in June 2023 inked its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. After leaping a series of regulatory hurdles, including a U.S. Justice Department lawsuit, the deal closed in mid-August. The acquisition shines a spotlight on the growing importance of home-based care in the continuum, but could accelerate consolidation in the space, according to James Dismond, CEO of MiraSol Health.
Read the full article: How Optum’s Amedisys Deal Could Shake Up the Hospice Market //
Source: https://hospicenews.com/2025/10/21/how-optums-amedisys-deal-could-shake-up-the-hospice-market/